CareCloud's stock surged 70% in Q2 2025, reflecting increased investor confidence and inclusion in the Russell Microcap Index.
Quiver AI Summary
CareCloud, Inc. reported a significant rise in its common stock, increasing approximately 70% in the second quarter of 2025, making it one of the top performers in the Russell Microcap® Index after being added to the index on June 30, 2025. The company attributes this growth to heightened investor confidence driven by its focus on AI innovation, strategic acquisitions, and improved financial positioning. Notable achievements for the first half of 2025 include the launch of an AI Center of Excellence, the resumption of M&A activities, and a strong cash position exceeding $10 million. Co-CEO Stephen Snyder emphasized that these developments reflect disciplined execution and set the stage for continued momentum in the latter half of the year, reinforcing CareCloud's commitment to delivering advanced healthcare technology solutions.
Potential Positives
- CareCloud's common stock rose approximately 70% during the second quarter of 2025, marking it as one of the top gainers in the Russell Microcap® Index for the period.
- The company was officially added to the Russell Microcap Index effective June 30, 2025, which enhances its visibility and credibility among investors.
- First half 2025 highlights include the launch of an AI Center of Excellence and the resumption of M&A activity targeting high-potential verticals, indicating a proactive approach to growth and innovation.
- CareCloud ended the quarter with over $10 million in cash and successfully converted 3.5 million Series A Preferred shares into Common Stock, strengthening its balance sheet and public float.
Potential Negatives
- The press release includes a disclaimer about forward-looking statements, indicating that the company's future performance may be uncertain and subject to various risks, which could undermine investor confidence.
- Despite showing a significant stock price increase, there is no indication of sustained past performance, highlighting a potential volatility issue that may concern investors.
- The mention of resumed M&A activity includes inherent risks associated with integrating new acquisitions, which could negatively impact operational stability if not managed well.
FAQ
What contributed to CareCloud's stock increase in Q2 2025?
CareCloud's stock rose about 70% due to increased investor confidence and strong performance following its addition to the Russell Microcap Index.
When was CareCloud added to the Russell Microcap Index?
CareCloud was officially added to the Russell Microcap Index effective June 30, 2025, after the annual reconstitution.
What is CareCloud's strategy for future growth?
CareCloud plans to accelerate AI innovation, resume acquisitions in high-potential verticals, and enhance its capital structure for long-term growth.
What recent milestones has CareCloud achieved in 2025?
In the first half of 2025, CareCloud launched an AI Center of Excellence and completed the conversion of 3.5 million Series A shares.
How can I stay updated on CareCloud's news and announcements?
You can follow CareCloud on LinkedIn, X, and Facebook, or visit their website at carecloud.com for the latest updates.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$CCLD Insider Trading Activity
$CCLD insiders have traded $CCLD stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $CCLD stock by insiders over the last 6 months:
- JOHN N DALY sold 15,000 shares for an estimated $31,649
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CCLD Hedge Fund Activity
We have seen 36 institutional investors add shares of $CCLD stock to their portfolio, and 10 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- AMERIPRISE FINANCIAL INC added 1,879,174 shares (+inf%) to their portfolio in Q1 2025, for an estimated $2,612,051
- CRESCENT GROVE ADVISORS, LLC added 179,936 shares (+inf%) to their portfolio in Q1 2025, for an estimated $250,111
- ACADIAN ASSET MANAGEMENT LLC added 168,156 shares (+481.9%) to their portfolio in Q1 2025, for an estimated $233,736
- MCDONALD PARTNERS LLC added 98,379 shares (+375.1%) to their portfolio in Q1 2025, for an estimated $136,746
- TWO SIGMA INVESTMENTS, LP added 96,998 shares (+420.0%) to their portfolio in Q1 2025, for an estimated $134,827
- CHAPIN DAVIS, INC. added 88,285 shares (+284.9%) to their portfolio in Q1 2025, for an estimated $122,716
- BANK OF AMERICA CORP /DE/ added 85,877 shares (+126289.7%) to their portfolio in Q1 2025, for an estimated $119,369
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
SOMERSET, N.J., July 10, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO) (“CareCloud” or the “Company”), a leader in AI-powered healthcare technology and revenue cycle management solutions, today announced that its common stock rose approximately 70% during the second quarter of 2025, making it among the top gainers in the Russell Microcap ® Index for the period.
The Company was officially added to the Russell Microcap Index effective June 30, 2025, following the annual reconstitution of the Russell indexes. The inclusion and strong performance underscore CareCloud’s growing visibility and investor confidence in its strategic direction.
“Our performance this quarter reflects growing investor confidence in our strategic direction, particularly as we accelerate AI innovation, re-engage in targeted acquisitions, and enhance our capital structure,” said Stephen Snyder, Co-CEO of CareCloud. “With a strengthened balance sheet, an expanding public float, and a renewed focus on delivering intelligent health solutions, we believe CareCloud is well positioned for long-term growth.”
First Half 2025 Highlights:
- Launched its new AI Center of Excellence
- Resumed M&A activity targeting high-potential verticals
- Completed conversion of 3.5 million Series A Preferred shares into Common Stock
- Ended the quarter with over $10 million in cash
-
Added to the Russell Microcap Index
The Company believes that these developments reflect CareCloud’s disciplined execution and position the Company for continued momentum into the second half of 2025.
About CareCloud
CareCloud, Inc. is a leading provider of healthcare technology solutions for medical practices and health systems. CareCloud’s comprehensive suite of revenue cycle, practice management, and patient engagement solutions is supported by emerging AI technologies to improve clinical and financial outcomes.
Follow CareCloud on LinkedIn , X and Facebook .
For additional information, please visit our website at carecloud.com . To listen to video presentations by CareCloud’s management team, read recent press releases and view the latest investor presentation, please visit ir.carecloud.com .
Disclaimer
This press release is for information purposes only and does not constitute an offer to sell or solicitation of an offer to buy, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of such state or jurisdiction.
Forward-Looking Statements
This press release contains various forward-looking statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements relate to anticipated future events, future results of operations or future financial performance. In some cases, you can identify forward-looking statements by terminology such as “may,” “might,” “will,” “shall,” “should,” “could”, “intends,” “expects,” “plans,” “goals,” “projects,” “anticipates,” “believes,” “seeks,” “estimates,” “predicts,” “possible,” “potential,” “target,” or “continue” or the negative of these terms or other comparable terminology.
Our operations involve risks and uncertainties, many of which are outside our control, and any one of which, or a combination of which, could materially affect our results of operations and whether the forward-looking statements ultimately prove to be correct. Forward-looking statements in this press release include, without limitation, statements reflecting management's expectations for future financial performance and operating expenditures, expected growth, profitability and business outlook, and the expected results from the integration of our acquisitions. Past operational or stock price performance is not an indication of future performance.
These forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are only predictions, are uncertain and involve substantial known and unknown risks, uncertainties and other factors which may cause our (or our industry’s) actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance expressed or implied by these forward-looking statements. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all of the risks and uncertainties that could have an impact on the forward-looking statements, including without limitation, risks and uncertainties relating to the Company’s ability to manage growth, migrate newly acquired customers and retain new and existing customers, maintain cost-effective global operations, increase operational efficiency and reduce operating costs, predict and properly adjust to changes in reimbursement and other industry regulations and trends, retain the services of key personnel, develop new technologies, upgrade and adapt legacy and acquired technologies to work with evolving industry standards, compete with other companies’ products and services competitive with ours, and other important risks and uncertainties referenced and discussed under the heading titled “Risk Factors” in the Company’s filings with the Securities and Exchange Commission.
The statements in this press release are made as of the date of this press release, even if subsequently made available by the Company on its website or otherwise. The Company does not assume any obligations to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made.
SOURCE: CareCloud
Company Contact:
Norman Roth
Interim Chief Financial Officer and Corporate Controller
CareCloud, Inc.
[email protected]
Investor Contact:
Stephen Snyder
Co-Chief Executive Officer
CareCloud, Inc.
[email protected]